Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Finasteride and PP405 Interaction: Compatible | Peptide Database

Compound Profiles Finasteride 5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, an

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Finasteride

5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH

Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).

PP405

MPC Inhibitor | Hair Follicle Stem Cell Activation

PP405 is a dual inhibitor of the mitochondrial pyruvate carrier complex, targeting both the MPC1 and MPC2 subunits. Under normal conditions, the MPC transports pyruvate from the cytoplasm into the mitochondrial matrix, where it enters the tricarboxylic acid (TCA) cycle for oxidative metabolism.

Combined Organ Load

Frequently Asked Questions

Can I take Finasteride with PP405?

Yes, Finasteride and PP405 can generally be taken together. Completely different mechanisms of action. Finasteride blocks DHT production via 5-alpha reductase inhibition, while PP405 targets hair follicle stem cell metabolism via MPC inhibition. Combination could be synergistic by addressing both hormonal miniaturization and stem cell dormancy simultaneously.

Is Finasteride and PP405 safe together?

Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.

What are the interactions between Finasteride and PP405?

Completely different mechanisms of action. Finasteride blocks DHT production via 5-alpha reductase inhibition, while PP405 targets hair follicle stem cell metabolism via MPC inhibition. Combination could be synergistic by addressing both hormonal miniaturization and stem cell dormancy simultaneously. This assessment has 90% confidence and is based on documented research data.

How should I time Finasteride and PP405?

Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and PP405 has a half-life of Topical application; exact pharmacokinetics not published. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Protects liver tissue through normalizing immune and antioxidant status. Restores liver functions in both acute and chronic hepatitis models. Shows protective properties in liver fibroid induration models. Decondenses chromatin to restore youthful gene expression patterns. Maximum hepatoprotective effects occur during aging. Activates silent genes including ribosomal genes for improved protein synthesis. Normalizes immune function alongside liver protective effects.

Source: peptide-db.com ↗

Community Research

Join others researching NA-Selank Amidate — share findings, ask questions, and learn from real experiences NA-Selank Amidate is an enhanced version of Selank, the anxiolytic nootropic peptide developed at Russia's Institute of Molecular Genetics. The N-acetyl group improves blood-brain barrier penetration and creates more stable metabolites, while the C-terminal amidation further enhances metabolic stability and receptor binding. Unlike benzodiazepines, it provides anxiety relief without sedation, dependency, or cognitive impairment. NA-Selank Amidate modulates multiple neurotransmitter systems including GABA, dopamine, and serotonin, while regulating brain-derived neurotrophic factor (BDNF). It allosterically modulates GABAA receptors without causing the sedation or dependency of benzodiazepines. The peptide activates serotonin metabolism in the hypothalamus and brainstem, and increases BDNF levels to promote neuronal growth and differentiation.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Standard administration route; allows precise dosing and rapid hormone stimulation. Gonadotropin stimulation 100-200mcg Single dose or 2-3x weekly SubQ Fertility support 0.4-1.0 nmol/kg (50-150mcg) As directed by physician SubQ (KP-54) Sexual function (clinical) 1 nmol/kg/h 75-minute IV infusion IV infusion

Source: peptide-db.com ↗
Side effects

Common Side Effects

Estrogen management difficulty -- 7-alpha-methyl-estradiol is harder to control with conventional aromatase inhibitors Water retention and bloating, particularly at doses above 10 mg/day Elevated blood pressure, often linked to water retention and estrogenic load Mood changes including irritability, emotional sensitivity, or anxiety (frequently estrogen-related) Profoundly suppressive of the HPG axis -- LH and FSH driven to near-zero even at low doses Injection frequency burden (daily or twice-daily with acetate ester) Mild acne and oily skin Increased appetite

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides